Protagonist Therapeutics, Inc. · NASDAQ:PTGX
Protagonist Therapeutics, Inc. shareholders
As of Sep 30, 2026, 370 institutions reported holding Protagonist Therapeutics, Inc. Largest: BlackRock, Vanguard and Farallon Capital Management, L.L.C. New holders, exits, insiders and big stakes, each with its filing.
| Holder | Shares | % of Protagonist Therapeutics, Inc. | Change | Filed |
|---|---|---|---|---|
| BlackRock | 10.7M | +426K | Nov 13, 2026 | |
| Vanguard | 7.13M | +110K | Nov 16, 2026 | |
| Farallon Capital Management, L.L.C. | 6.44M | +89,000 | Nov 16, 2026 | |
| Rtw Investments, LP | 5.06M | no change | Nov 16, 2026 | |
| UBS | 4.08M | +573K | Nov 16, 2026 | |
| Wellington | 3.54M | +127K | Nov 16, 2026 | |
| State Street | 3.48M | +158K | Nov 12, 2026 | |
| Invesco | 2.84M | +497K | Nov 12, 2026 | |
| Johnson & Johnson | 2.45M | no change | Oct 26, 2026 | |
| Geode Capital | 1.8M | +59,071 | Nov 6, 2026 |